Healthcare & Life Sciences Events - Let's Meet

March 25-26, 2019 | London, UK | Healthcare & Life Sciences

Digital Health Rewired

Digital Health Rewired is the new multi-event conference and exhibition in London focused on joining up and integrating health and care through the transformational use of technology and new ways of working.

March 25-27, 2019 | Vienna, Austria | Healthcare & Life Sciences

Bio Europe Spring

Bio Europe Spring brings together the “who’s who” from the biotech, pharma and finance segments to allow delegates to meet more key decision makers in three days of partnering meetings than they could in a whole year.

April 9-11, 2019 | Berlin, Germany | Healthcare & Life Sciences

DMEA 2019

DataArt is exhibiting at DMEA 2019 (formerly known as conhIT – Connecting Healthcare IT). DMEA will retain conhIT’s successful concepts in order, step by step, to become the platform representing every digital field of interest to all players in the healthcare system, both now and in the future.

June 3-6, 2019 | Philadelphia, PA | Healthcare & Life Sciences

Bio International Convention 2019

The BIO International Convention is hosted by the Biotechnology Innovation Organization (BIO), which represents more than 1,100 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations.

June 23-27, 2019 | San Diego, CA | Healthcare & Life Sciences

DIA 2019 Global Annual Meeting

The DIA 2019 Global Annual Meeting brings together thousands of innovators from around the globe. Sessions will include distinguished speakers and expert panelists from regulatory, industry, patient advocacy, and academia. Engage with global decision-makers and influencers that you would not otherwise have access to.

September 17-18, 2019 | Boston, MA | Healthcare & Life Sciences

DPharm 2019

DPharm is the annual event to get the best access to innovative ideas, especially disruptive ones, to advance drug development operations from pharma and outside industry leaders with a view to reducing the burden to patients and investigators.